Abstract | BACKGROUND AND PURPOSE: METHODS: RESULTS: There was no significant difference in the incidence of any cancer among participants assigned B vitamins compared with placebo (4.04% versus 4.59%; risk ratio, 0.86; 95% CI, 0.70-1.07) and no difference in cancer mortality (2.35% versus 2.09%; risk ratio, 1.09; 0.81-1.46). Among 1899 patients with diabetes, the incidence of cancer was higher among participants assigned B vitamins compared with placebo (5.35% versus 3.28%; adjusted risk ratio, 2.21; 1.31-3.73), whereas among 6168 patients without diabetes, the incidence of cancer was lower among participants assigned B vitamins compared with placebo (3.66% versus 5.03%; adjusted risk ratio, 0.67; 0.51-0.87; P for interaction=0.0001). CONCLUSIONS:
|
Authors | Graeme J Hankey, John W Eikelboom, Qilong Yi, Kennedy R Lees, Christopher Chen, Denis Xavier, Jose C Navarro, Udaya K Ranawaka, Wasim Uddin, Stefano Ricci, John Gommans, Reinhold Schmidt, VITAmins TO Prevent Stroke (VITATOPS) Trial Study Group |
Journal | Stroke
(Stroke)
Vol. 43
Issue 6
Pg. 1572-7
(Jun 2012)
ISSN: 1524-4628 [Electronic] United States |
PMID | 22474057
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Double-Blind Method
- Female
- Humans
- Ischemic Attack, Transient
(complications, mortality)
- Male
- Neoplasms
(mortality, prevention & control)
- Stroke
(complications, mortality)
- Vitamin B Complex
(administration & dosage)
|